Targeted fluorine-containing butylphthalide as well as synthesis method and application thereof
By introducing fluorine atoms and methyl groups into butylphthalide, the synthetic targeting of fluorine-containing butylphthalide has solved the problems of its water solubility and low bioavailability, significantly improving the anticoagulation effect and biological activity, becoming a therapeutic shortage Potential drugs for hematologic stroke.
Patent Information
- Application Number
- CN202411054543.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing butylphthalide has low water solubility, limited anti-platelet agglutination activity, difficulty in storage and preparation, and low bioavailability, resulting in hindering its clinical application.
By introducing fluorine atoms and methyl groups, a synthetic method targeting fluorobutylphthalide is designed, using 5-substituted salicyle as the starting material, and is protected by aldehyde group, benzene cycloacetylation, Pinnick oxidation, The six-step reaction of the addition cyclization, borohydrooxidation and deoxyfluorination of the reagent targeted fluorobutylphthalide is synthesized, optimizing the material and process conditions of each step to improve product yield and safety.
It significantly improves the anticoagulant effect of targeting fluorobutylphthalide, significantly promotes the proliferation of PC12 cells, and is stronger than the same concentration of NBP, has better biological activity and higher potential drug potential for the treatment of ischemic stroke. .
Smart Images

Figure CN118978500A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of a synthetic method for targeted fluorinated butylphthalide, and in particular to a targeted fluorinated butylphthalide, a synthetic method and an application thereof. Background Art
[0002] NBP is extracted from celery seeds, which are naturally eaten, and has a celery aroma. It is also called apigenin. Its chemical name is 3-n-butyl-1(3H)-isobenzofuranone, and it has three structures: (S)-3-n-butylphthalide, (R)-3-n-butylphthalide, and (RS)-3-n-butylphthalide. NBP is commonly used to treat mild and moderate acute ischemic stroke, cerebral arteriosclerosis and other central nervous system diseases. Its main mechanism of action is to improve microcirculation in the ischemic area of the brain, promote angiogenesis and increase cerebral blood flow in the ischemic area.
[0003] In response to the above-mentioned related technologies, the inventors found that the clinical application of NBP was hindered due to its low water solubility, limited antiplatelet aggregation activity, difficult storage and preparation, and low bioavailability. Therefore, the NBP structure was modified and transformed to prepare derivatives and analogues in order to improve its efficacy and bioavailability. Summary of the invention
[0004] In order to improve the defects of existing butylphthalide derivatives in clinical applications, such as poor efficacy and bioavailability, the present application provides a synthesis method of a targeted fluorinated butylphthalide and a preparation method thereof.
[0005] In the first aspect, the present application provides a targeted fluorinated butylphthalide, using the following technical solution:
[0006] A targeted fluorinated butylphthalide having the following general structural formula:
[0007] Wherein R is located at position 3 of the benzene ring, and the R includes at least one of H, Cl, F or Br.
[0008] Through the above technical scheme, the present application selectively introduces fluorine atoms into biologically active molecules to improve pharmacological behavior. Fluorine atoms replacing hydrogen have the advantages of small size, strong electronegativity and the ability to enhance biological efficacy without increasing toxicity. In addition, methyl is the most common group in drug molecules after hydrogen and nitrogen. The clever introduction of methyl groups can effectively improve the physicochemical properties of drug molecules, enhance the biological activity of drugs, and enhance the metabolic properties of drugs. Therefore, the present application introduces fluorine atoms at position 1 and methyl groups at position 2 to synthesize unsubstituted NBP derivatives on the benzene ring.
[0009] In the second aspect, the present application provides a method for synthesizing a targeted fluorinated butylphthalide, using the following technical solution:
[0010] A method for synthesizing a targeted fluorinated butylphthalide comprises the following steps:
[0011] S1, taking compound 5-substituted salicylaldehyde and acetylhydrazine as raw materials and adding solvent 1, reacting once and collecting to obtain compound c;
[0012] S2, taking compound c and lead tetraacetate as raw materials, performing secondary reaction and collecting to obtain compound d;
[0013] S3, taking compound d as raw material and adding pH buffer, adding H2O2 and NaClO2, selecting acetonitrile aqueous solution as solvent 2, reacting three times and collecting compound e;
[0014] S4, under a nitrogen atmosphere, placing compound e in solvent 3, then adding 3-butenylmagnesium bromide dropwise thereto at an ice-water bath temperature, mixing, and adding a ring-closing agent, and performing the reaction treatment four times to collect compound g;
[0015] S5, using compound g as a raw material, adding a borohydride reagent and trisodium borate to carry out five reactions, and collecting compound h;
[0016] S6. Dissolve compound h in anhydrous DCM under a protective gas atmosphere, cool it down and add a fluorinating agent. After the dropwise addition, react at room temperature to prepare the targeted fluorinated butylphthalide.
[0017] Through the above technical scheme, the present application designs a route for synthesizing NBP derivatives, using 5-substituted salicylaldehyde as the starting material, and synthesizing the compound through six steps of aldehyde protection, phenyl ring acetylation, Pinnick oxidation, Grignard reagent addition cyclization, hydroboration oxidation and deoxyfluorination. The overall scheme is simple and easy to implement with high yield, which effectively improves the safety and operability of the reaction.
[0018] Furthermore, in the single reaction described in step S1, the solvent 1 includes at least one of methanol or ethanol, and the parameters of the single reaction are: reaction treatment at 75-90° C. for 10-15 hours.
[0019] Furthermore, the addition ratio of compound c and lead tetraacetate in step S2 is 1:(1-1.5) in molar ratio.
[0020] Furthermore, the pH buffer described in step S3 is NaH2PO4, the molar ratio of NaH2PO4, NaClO2 and H2O2 is 1.5:(1-4):(1-3), and the stability of the three reactions is -5-5°C.
[0021] Furthermore, the specific preparation steps of step S4 adopt the following technical scheme:
[0022] Under a nitrogen atmosphere, compound e is added to tetrahydrofuran, and then 3-butenylmagnesium bromide is added dropwise in an ice-water bath. After the addition is completed, the reaction is kept warm for 20-30 minutes. After the temperature is raised to room temperature, the reaction is treated and NH4Cl is added to quench the reaction. After adding 12 mol / L hydrochloric acid, the temperature is raised to 65-75°C and kept warm for 45-80 minutes to prepare compound g.
[0023] Furthermore, the borohydride reagent in step S5 includes any one of 9-borabicyclo[3.3.1]nonane, borane tetrahydrofuran complex or borane dimethyl sulfide complex.
[0024] Furthermore, the fluorinating agent in step S6 includes any one of diethylaminosulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, pyridine-2-sulfonyl fluoride, perfluorobutylsulfonyl fluoride and SF4.
[0025] Through the above technical scheme, the present application optimizes the materials and preparation process conditions in each step, thereby further improving the yield of the product, reducing costs, and effectively improving the safety and operability of the reaction.
[0026] In a third aspect, the present application provides an application scope of a targeted fluorinated butylphthalide.
[0027] A targeted fluorinated butylphthalide can be used to treat cardiovascular and cerebrovascular diseases.
[0028] Through the above technical scheme, the present application conducts biological activity tests on the targeted fluorinated butylphthalide. Compared with NBP, the targeted fluorinated butylphthalide prepared by the present application has better anticoagulant effect, significantly promotes the proliferation of PC12 cells, and the effect is significantly stronger than that of NBP at the same concentration, further indicating that the targeted fluorinated butylphthalide prepared by the present application can become a potential drug for the treatment of ischemic stroke.
[0029] In summary, this application has the following beneficial effects:
[0030] First, the present application selectively introduces fluorine atoms into biologically active molecules to improve pharmacological behavior. Fluorine atoms replacing hydrogen have the advantages of small size, strong electronegativity, and the ability to enhance biological efficacy without increasing toxicity. In addition, methyl is the most common group in drug molecules after hydrogen and nitrogen. The clever introduction of methyl groups can effectively improve the physicochemical properties of drug molecules, enhance the biological activity of drugs, and enhance the metabolic properties of drugs. Therefore, the present application introduces fluorine atoms at position 1 and methyl groups at position 2 to synthesize unsubstituted NBP derivatives on the benzene ring.
[0031] Second, the present application designs a route for synthesizing NBP derivatives, using 5-substituted salicylaldehyde as the starting material, and synthesizing the compound through six steps of aldehyde protection, phenyl ring acetylation, Pinnick oxidation, Grignard reagent addition cyclization, hydroboration oxidation and deoxyfluorination. The overall scheme is simple and easy to implement with high yield, which effectively improves the safety and operability of the reaction.
[0032] Third, the present application conducted a biological activity test on the targeted fluorinated butylphthalide. Compared with NBP, the targeted fluorinated butylphthalide prepared in the present application has a better anticoagulant effect and significantly promotes the proliferation of PC12 cells. The effect is significantly stronger than that of NBP at the same concentration, which further illustrates that the targeted fluorinated butylphthalide prepared in the present application can become a potential drug for the treatment of ischemic stroke. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show a certain embodiment of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.
[0034] Figure 1 It is the reaction equation in Example 1 of the present invention.
[0035] Figure 2 It is the target fluorinated butylphthalide of Example 2 of the present application 1 HNMR spectrum;
[0036] Figure 3 It is the target fluorinated butylphthalide of Example 2 of the present application 13 C NMR spectrum;
[0037] Figure 4 It is the target fluorinated butylphthalide of Example 2 of the present application 19 F NMR spectrum. DETAILED DESCRIPTION
[0038] The present application is further described in detail below in conjunction with embodiments.
[0039] In the examples of the present application, the raw materials and instruments used are as follows, but not limited thereto:
[0040] The present application is further described in detail below in conjunction with embodiments.
[0041] Example 1
[0042] A targeted fluorinated butylphthalide having the following general structural formula:
[0043]
[0044] A method for synthesizing a targeted fluorinated butylphthalide comprises the following steps:
[0045] S1. Take a 250mL clean and dry round-bottom flask, add a magnetic stirrer, and then add compound 5-substituted salicylaldehyde (20.0mmol, 1.0equiv.) and 60mL ethanol in sequence. After sufficient stirring, add compound acetylhydrazine (22mmol, 1.1equiv.), continue stirring at room temperature for 5min, and a white solid precipitates. Heat it to 75°C and reflux for 15h. TLC monitors the completion of the reaction (DCM / MeOH=9 / 1, v / v), cool it to room temperature, filter it, wash the filter cake with petroleum ether, and obtain a white needle-shaped solid. Dry it in a 50°C oven to obtain a dry compound c with a yield of 95%, which can be directly used in the next step.
[0046] S2. Take a 250mL clean and dry round-bottom flask, add a magnetic stirrer and then add compound c (15.0mmol, 1.0equiv.), add 35mL tetrahydrofuran, and stir in an ice bath for 10min; then add lead tetraacetate (6650.7mg, 15.0mmol, 1equiv.) in batches, add a batch every 10min, and each batch is 1662.7mg. After the last batch is added, continue to stir in an ice bath for 20min, and then warm to room temperature to react for 2h; TLC monitors the completion of the reaction (developing solvent is DCM), filter, and spin-dry the filtrate to obtain a dark brown viscous substance. The filter cake is washed with ethyl acetate and diluted and concentrated, washed with water and the organic phase is collected, and the organic phase is washed with saturated sodium bicarbonate solution at room temperature and saturated brine at room temperature in turn, added with anhydrous sodium sulfate to dry, filtered, and concentrated by rotary evaporation. The residue is separated by column chromatography to obtain white crystalline compound d. (The column chromatography eluent is PE / EA=15 / 1, v / v)
[0047] S3. Take a 100mL clean and dry round-bottom flask, add a magnetic stirrer, add compound d (5.76mmol, 1.0equiv.), add 15mL acetonitrile, 4mL water, stir well to dissolve, transfer to a 0℃ low temperature constant temperature reaction bath, add sodium dihydrogen phosphate (8.64mmol, 1.5equiv.) and 30wt% hydrogen peroxide aqueous solution (2.08mmol, 1.0equiv.) in sequence, add sodium chlorite (5.76mmol, 1.0equiv.), and react in an ice bath for 1h. TLC monitors the completion of the reaction (PE / EA=5 / 1, v / v), adjust the pH to 3-4 with 3N HCl, stir for 30min, transfer the reaction solution to a separatory funnel, then dilute with appropriate amounts of ethyl acetate and water, separate the organic phase, and continue to extract the aqueous layer with ethyl acetate. Combine the organic phases, wash with saturated brine at room temperature, dry over anhydrous sodium sulfate, filter, and concentrate by rotary evaporation to remove the solvent to obtain a yellow oily compound e, which is directly used for the next step without purification.
[0048] S4. Take a 100mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, add compound e (5.0mmol, 1.0equiv.) to the Shrek tube, then connect a double-row tube, replace nitrogen 3 times, add 3mL of anhydrous tetrahydrofuran under nitrogen atmosphere, stir and dissolve thoroughly. Then move the reaction tube to a 0℃ low temperature constant temperature reaction bath, slowly add compound 3-butenylmagnesium bromide (15mmol, 0.5MinTHF, 3.0equiv.), react in an ice bath for 20min, then warm to room temperature for 2h, then add 10wt% ammonium chloride (5.5mmol, 1.1equiv.) solution to quench the reaction solution under ice bath conditions, then add 12NHCl (250mmol, 50.0equiv.), and heat to 65℃ for 80min. The reaction was completed by TLC monitoring (PE / EA=7 / 1, v / v), the reaction solution was extracted with ethyl acetate, the organic layers were combined, washed with water and saturated brine, the organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The residue was separated by column chromatography to obtain a light yellow oily compound g (column chromatography eluent: PE / EA=40 / 1-30 / 1, v / v).
[0049] S5. Take a 100mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, and add compound g (3.15mmol, 1.0equiv.) to the Shrek tube. Then connect a double-row tube, replace nitrogen 3 times, add 5mL of anhydrous tetrahydrofuran under a nitrogen atmosphere, and stir thoroughly to dissolve. Move the reaction tube to a 0℃ low-temperature constant temperature reaction bath, slowly drop 9-boranebicyclo[3.3.1]nonane (5.5mmol, 0.5MinTHF, 1.1equiv.), and slowly heat to room temperature to react for 3h after the drop. TLC monitors the complete reaction of the raw materials (PE / EA=7 / 1, v / v), and all become new points at the origin, transfer to a 0℃ low-temperature constant temperature reaction bath, add water to quench the reaction, add sodium perborate tetrahydrate (4.73mmol, 1.5equiv.), and react at room temperature for 1h. After the reaction, water was added for shaking, and the mixture was extracted with ethyl acetate. The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The residue was separated by column chromatography to obtain a colorless oily compound h (column chromatography eluent: PE / EA = 5 / 1-2 / 1, v / v).
[0050] S6. Take a 25mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, and add compound h (1.5mmol, 1.0equiv.) to the Shrek tube. Then connect the double-row tube, replace nitrogen 3 times, add 2mL of anhydrous DCM under nitrogen atmosphere, and stir and dissolve thoroughly. Then move the reaction tube to a -5℃ low-temperature constant temperature reaction bath, slowly add DAST (4.5mmol, 3.0equiv.), and slowly warm to room temperature after the drop is completed to react for 12h. TLC monitors the complete reaction of the raw material (PE / EA=2 / 1, v / v), add ice water to quench the reaction, and stir for 10min. Add water and shake, extract with ethyl acetate, combine the organic phases, wash with saturated brine, dry with anhydrous sodium sulfate, and concentrate by rotary evaporation. The residue is separated by column chromatography to obtain a colorless liquid compound targeting fluorinated butylphthalide (column chromatography eluent is PE / EA=18 / 1-16 / 1, v / v).
[0051] Example 2
[0052] A targeted fluorinated butylphthalide having the following general structural formula:
[0053]
[0054] A method for synthesizing a targeted fluorinated butylphthalide comprises the following steps:
[0055] S1. Take a 250mL clean and dry round-bottom flask, add a magnetic stirrer, and then add compound 5-substituted salicylaldehyde (20.0mmol, 1.0equiv.) and 60mL ethanol in sequence. After sufficient stirring, add compound acetylhydrazine (22mmol, 1.1equiv.), continue stirring at room temperature for 5min, and a white solid precipitates. Heat it to 80°C and reflux for 12h. TLC monitors the completion of the reaction (DCM / MeOH=9 / 1, v / v), cool it to room temperature, filter it, wash the filter cake with petroleum ether, and obtain a white needle-shaped solid. Dry it in a 50°C oven to obtain a dry compound c with a yield of 95%, which can be directly used in the next step.
[0056] S2. Take a 250mL clean and dry round-bottom flask, add a magnetic stirrer and then add compound c (15.0mmol, 1.0equiv.), add 35mL tetrahydrofuran, and stir in an ice bath for 10min; then add lead tetraacetate (7980.8mg, 18.0mmol, 1.2equiv.) in batches, add a batch every 10min, each batch of 1995.2mg, after the last batch is added, continue to stir in an ice bath for 20min, then warm to room temperature for 2h; TLC monitors the completion of the reaction (developing solvent is DCM), filter, and spin-dry the filtrate to obtain a dark brown viscous substance, wash the filter cake with ethyl acetate and dilute and concentrate, wash with water and collect the organic phase, wash the organic phase with saturated sodium bicarbonate solution at room temperature and saturated brine at room temperature in turn, add anhydrous sodium sulfate to dry, filter, and spin-dry. The residue is separated by column chromatography to obtain white crystalline compound d. (The column chromatography eluent is PE / EA=15 / 1, v / v)
[0057] S3, take a 100mL clean and dry round-bottom flask, add a magnetic stirrer, add compound d (5.76mmol, 1.0equiv.), add 15mL acetonitrile, 4mL water, stir well to dissolve, transfer to a 0℃ low temperature constant temperature reaction bath, add sodium dihydrogen phosphate (8.64mmol, 1.5equiv.) and 30wt% hydrogen peroxide aqueous solution (13.84mmol, 2.4equiv.) in sequence, add sodium chlorite (23.04mmol, 4.0equiv.), react in an ice bath for 1h. TLC monitors the completion of the reaction (PE / EA=5 / 1, v / v), adjust the pH to 3-4 with 3N HCl, stir for 30min, transfer the reaction solution to a separatory funnel, then dilute with appropriate amounts of ethyl acetate and water, separate the organic phase, and continue to extract the aqueous layer with ethyl acetate. The organic phases were combined, washed with saturated brine at room temperature, dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to remove the solvent to obtain yellow oily compound e, which was directly used in the next step without purification.
[0058] S4. Take a 100mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, add compound e (5.0mmol, 1.0equiv.) to the Shrek tube, then connect a double-row tube, replace nitrogen 3 times, add 3mL of anhydrous tetrahydrofuran under nitrogen atmosphere, stir and dissolve thoroughly. Then move the reaction tube to a 0℃ low temperature constant temperature reaction bath, slowly add compound 3-butenylmagnesium bromide (15mmol, 0.5MinTHF, 3.0equiv.), react in an ice bath for 30min, then warm to room temperature for 2h, then add 10wt% ammonium chloride (5.5mmol, 1.1equiv.) solution to quench the reaction solution under ice bath conditions, then add 12NHCl (250mmol, 50.0equiv.), and heat to 70℃ for 1h. The reaction was completed by TLC monitoring (PE / EA=7 / 1, v / v), the reaction solution was extracted with ethyl acetate, the organic layers were combined, washed with water and saturated brine, the organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The residue was separated by column chromatography to obtain a light yellow oily compound g (column chromatography eluent: PE / EA=40 / 1-30 / 1, v / v).
[0059] S5. Take a 100mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, and add compound g (3.15mmol, 1.0equiv.) to the Shrek tube. Then connect a double-row tube, replace nitrogen 3 times, add 5mL of anhydrous tetrahydrofuran under a nitrogen atmosphere, and stir thoroughly to dissolve. Move the reaction tube to a 0℃ low-temperature constant temperature reaction bath, slowly drop 9-boranebicyclo[3.3.1]nonane (5.5mmol, 0.5MinTHF, 1.1equiv.), and slowly heat to room temperature to react for 3h after the drop. TLC monitors the complete reaction of the raw materials (PE / EA=7 / 1, v / v), and all become new points at the origin, transfer to a 0℃ low-temperature constant temperature reaction bath, add water to quench the reaction, add sodium perborate tetrahydrate (4.73mmol, 1.5equiv.), and react at room temperature for 1h. After the reaction, water was added for shaking, and the mixture was extracted with ethyl acetate. The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The residue was separated by column chromatography to obtain a colorless oily compound h (column chromatography eluent: PE / EA = 5 / 1-2 / 1, v / v).
[0060] S6. Take a 25mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, and add compound h (1.5mmol, 1.0equiv.) to the Shrek tube. Then connect the double-row tube, replace nitrogen 3 times, add 2mL of anhydrous DCM under nitrogen atmosphere, and stir and dissolve thoroughly. Then move the reaction tube to a -5℃ low-temperature constant temperature reaction bath, slowly add DAST (4.5mmol, 3.0equiv.), and slowly warm to room temperature after the drop is completed to react for 12h. TLC monitors the complete reaction of the raw material (PE / EA=2 / 1, v / v), add ice water to quench the reaction, and stir for 10min. Add water and shake, extract with ethyl acetate, combine the organic phases, wash with saturated brine, dry with anhydrous sodium sulfate, and concentrate by rotary evaporation. The residue is separated by column chromatography to obtain a colorless liquid compound targeting fluorinated butylphthalide (column chromatography eluent is PE / EA=18 / 1-16 / 1, v / v).
[0061] Example 3
[0062] A targeted fluorinated butylphthalide having the following general structural formula:
[0063]
[0064] A method for synthesizing a targeted fluorinated butylphthalide comprises the following steps:
[0065] S1. Take a 250mL clean and dry round-bottom flask, add a magnetic stirrer, and then add compound 5-substituted salicylaldehyde (20.0mmol, 1.0equiv.) and 60mL ethanol in sequence. After sufficient stirring, add compound acetylhydrazine (22mmol, 1.1equiv.), continue stirring at room temperature for 5min, and a white solid precipitates. Heat it to 90°C and reflux for 10h. TLC monitors the completion of the reaction (DCM / MeOH=9 / 1, v / v), cool it to room temperature, filter it, wash the filter cake with petroleum ether, and obtain a white needle-shaped solid. Dry it in a 50°C oven to obtain a dry compound c with a yield of 95%, which can be directly used in the next step.
[0066] S2. Take a 250mL clean and dry round-bottom flask, add a magnetic stirrer and then add compound c (15.0mmol, 1.0equiv.), add 35mL tetrahydrofuran, and stir in an ice bath for 10min; then add lead tetraacetate (9976mg, 18.75mmol, 1.5equiv.) in batches, add a batch every 10min, each batch of 2494mg, after the last batch is added, continue to stir in an ice bath for 20min, then warm to room temperature for 2h; TLC monitors the completion of the reaction (developing solvent is DCM), filter, and spin-dry the filtrate to obtain a dark brown viscous substance, wash the filter cake with ethyl acetate and dilute and concentrate, wash with water and collect the organic phase, wash the organic phase with saturated sodium bicarbonate solution at room temperature and saturated brine at room temperature in turn, add anhydrous sodium sulfate to dry, filter, and spin-evaporate and concentrate. The residue is separated by column chromatography to obtain white crystalline compound d. (The column chromatography eluent is PE / EA=15 / 1, v / v)
[0067] S3. Take a 100mL clean and dry round-bottom flask, add a magnetic stirrer, add compound d (5.76mmol, 1.0equiv.), add 15mL acetonitrile, 4mL water, stir well to dissolve, transfer to a 0℃ low temperature constant temperature reaction bath, add sodium dihydrogen phosphate (8.64mmol, 1.5equiv.) and 30wt% hydrogen peroxide aqueous solution (17.3mmol, 3equiv.) in sequence, add sodium chlorite (23.04mmol, 4.0equiv.), and react in an ice bath for 1h. TLC monitors the completion of the reaction (PE / EA=5 / 1, v / v), adjust the pH to 3-4 with 3N HCl, stir for 30min, transfer the reaction solution to a separatory funnel, then dilute with appropriate amounts of ethyl acetate and water, separate the organic phase, and continue to extract the aqueous layer with ethyl acetate. Combine the organic phases, wash with saturated brine at room temperature, dry over anhydrous sodium sulfate, filter, and concentrate by rotary evaporation to remove the solvent to obtain a yellow oily compound e, which is directly used for the next step without purification.
[0068] S4. Take a 100mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, add compound e (5.0mmol, 1.0equiv.) to the Shrek tube, then connect a double-row tube, replace nitrogen 3 times, add 3mL of anhydrous tetrahydrofuran under nitrogen atmosphere, stir and dissolve thoroughly. Then move the reaction tube to a 0℃ low temperature constant temperature reaction bath, slowly add compound 3-butenylmagnesium bromide (15mmol, 0.5MinTHF, 3.0equiv.), react in an ice bath for 30min, then warm to room temperature for 2h, then add 10wt% ammonium chloride (5.5mmol, 1.1equiv.) solution to quench the reaction solution under ice bath conditions, then add 12NHCl (250mmol, 50.0equiv.), and heat to 75℃ for 45min. The reaction was completed by TLC monitoring (PE / EA=7 / 1, v / v), the reaction solution was extracted with ethyl acetate, the organic layers were combined, washed with water and saturated brine, the organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The residue was separated by column chromatography to obtain a light yellow oily compound g (column chromatography eluent: PE / EA=40 / 1-30 / 1, v / v).
[0069] S5. Take a 100mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, and add compound g (3.15mmol, 1.0equiv.) to the Shrek tube. Then connect a double-row tube, replace nitrogen 3 times, add 5mL of anhydrous tetrahydrofuran under a nitrogen atmosphere, and stir thoroughly to dissolve. Move the reaction tube to a 0℃ low-temperature constant temperature reaction bath, slowly drop 9-boranebicyclo[3.3.1]nonane (5.5mmol, 0.5MinTHF, 1.1equiv.), and slowly heat to room temperature to react for 3h after the drop. TLC monitors the complete reaction of the raw materials (PE / EA=7 / 1, v / v), and all become new points at the origin, transfer to a 0℃ low-temperature constant temperature reaction bath, add water to quench the reaction, add sodium perborate tetrahydrate (4.73mmol, 1.5equiv.), and react at room temperature for 1h. After the reaction, water was added for shaking, and the mixture was extracted with ethyl acetate. The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The residue was separated by column chromatography to obtain a colorless oily compound h (column chromatography eluent: PE / EA = 5 / 1-2 / 1, v / v).
[0070] S6. Take a 25mL clean and dry Shrek tube, add a magnetic stirrer of appropriate size, and add compound h (1.5mmol, 1.0equiv.) to the Shrek tube. Then connect the double-row tube, replace nitrogen 3 times, add 2mL of anhydrous DCM under nitrogen atmosphere, and stir and dissolve thoroughly. Then move the reaction tube to a -5℃ low-temperature constant temperature reaction bath, slowly add DAST (4.5mmol, 3.0equiv.), and slowly warm to room temperature after the drop is completed to react for 12h. TLC monitors the complete reaction of the raw material (PE / EA=2 / 1, v / v), add ice water to quench the reaction, and stir for 10min. Add water and shake, extract with ethyl acetate, combine the organic phases, wash with saturated brine, dry with anhydrous sodium sulfate, and concentrate by rotary evaporation. The residue is separated by column chromatography to obtain a colorless liquid compound targeting fluorinated butylphthalide (column chromatography eluent is PE / EA=18 / 1-16 / 1, v / v).
[0071] It should be noted that the fluorinating agent described in step S6 of the present application includes but is not limited to any one of diethylaminosulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, pyridine-2-sulfonyl fluoride, perfluorobutylsulfonyl fluoride, sulfuryl fluoride, sulfuryl chloride and SF4.
[0072] Performance Testing
[0073] The performance test of the synthesis method of the targeted fluorinated butylphthalide prepared in Examples 1-3 was performed:
[0074] The compounds c, d, e, f, g, h and the targeted fluorinated butylphthalide prepared in S1-S6 in Example 2 were subjected to spectrum detection. The specific spectrum is shown in Figure 2-4 As shown;
[0075] From its 1 H NMR spectrum ( Figure 2 ) we can see that there are fifteen hydrogen atoms in the figure, which corresponds exactly to the number of hydrogen atoms in the compound. There are three groups of peaks with integrals of 2, 1, and 1 at the chemical shift of δ=7.83-7.59ppm, corresponding to the four hydrogens on the benzene ring; at the chemical shifts of δ=4.41 (t, J=6.0Hz) ppm and δ=4.29 (t, J=6.0Hz) ppm, two groups of triplet peaks with integral 1 are formed under the influence of fluorine, corresponding to the two hydrogens at the 4th position; at the chemical shift of δ=2.09-1.95ppm, there is a group of multiple peaks with integral 2, corresponding to the two hydrogens at the 1st position; at the chemical shift of δ=1.62ppm, there is a group of singlet peaks with integral 3, corresponding to the three hydrogens on the methyl group; at the chemical shifts of δ=1.61-1.51ppm, δ=1.26-1.22ppm and δ=0.95-0.86ppm, there are three groups of multiple peaks with integrals of 2, 1, and 1, corresponding to the four hydrogens at the 2nd and 3rd positions.
[0076] right13 C NMR spectrum analysis ( Figure 3 ). There is a carbon atom peak at a chemical shift of δ = 169.98ppm, corresponding to the carbon at the carbonyl position of the isobenzofuran ring; there are six carbon atom singlets at a chemical shift of δ = 153.66-120.87ppm, corresponding to the six carbon atoms on the benzene ring; there is a carbon atom peak at a chemical shift of δ = 87.45ppm, corresponding to the carbon atoms connected to the methyl group and the fatty chain on the lactone ring; there is a group of doublets at a chemical shift of δ = 83.70ppm (d, J = 164.9Hz) formed by the splitting of fluorine atoms, corresponding to the carbon directly connected to the fluorine atom (position 4). atom; there is a carbon atom peak at the chemical shift of δ = 39.52ppm, which corresponds to the carbon atom at position 1 of the fatty chain; there is a set of double peaks formed by the splitting of fluorine atoms at the chemical shift of δ = 30.19ppm (d, J = 19.6Hz), which corresponds to the carbon atom at position 3 of the fatty chain; there is a carbon atom peak at the chemical shift of δ = 26.05ppm, which corresponds to the carbon atom on the methyl group; there is a set of double peaks formed by the splitting of fluorine atoms at the chemical shift of δ = 19.60ppm (d, J = 5.1Hz), which corresponds to the carbon atom at position 2 of the fatty chain.
[0077] Finally, the compound 19 F NMR spectrum analysis ( Figure 4 ). There is a single peak at the position of chemical shift δ = -218.60 ppm, which corresponds to the fluorine at the end of the compound's fatty chain. In summary, it can be determined that this compound is exactly what we predicted.
[0078] (2) At the same time, the synthesized targeted fluorinated butylphthalide was subjected to a preliminary determination of its in vitro platelet antiaggregation activity. The specific determination scheme is as follows: blood was drawn from the heart of a rabbit weighing 1.7 to 2.1 kg, and the blood was mixed with 3.8% (volume fraction) sodium citrate in a ratio of 1:9 as an anticoagulant. First, the platelet-rich plasma (PRP) was prepared by centrifugation at 1000 rpm (Revolutions per minute) for 10 minutes. Then, the remaining portion was centrifuged at 3000 rpm for 15 minutes to obtain platelet-poor plasma (PPP). The platelet aggregation activity test was performed using Born's turbidimetric method. Add 280μL PRP and 10μL of different concentrations (2000, 1000, 500, 200, 10μM) of the test compound to the assay tube, incubate for 5 minutes, then add 10μL of inducers ADP and AA (final concentration 10μM), observe and record the maximum platelet aggregation rate within 5 minutes, measure each concentration in parallel 5 times, and take the average value. Then use GraphPad prism 6.07 software to calculate the half effective inhibitory concentration (IC50) of NBP derivatives 1i-4i in vitro antiplatelet aggregation. Set up a blank control group (only add normal saline) and a positive control group (add NBP and clinically commonly used anticoagulant drug ASP). The specific test is shown in the following table:
[0079] Table 1 Performance test table
[0080] project ADP / (mM) AA(mM) Example 1 0.7272 0.0838 Example 2 0.6908 0.806 Example 3 0.7157 0.0815 NBP 1.3360 0.2989 ASP 1.1390 0.0352
[0081] (3) The MTT colorimetric method was used to investigate the effect of NBP derivatives 1i-4i on the proliferation of PC12 cells. PC12 cells were cultured with DMEM (Dulbecco's modification of eagle's medium) cell culture medium containing 10% calf serum and placed in an incubator at 37°C and 5% CO2. The medium was changed every other day, and the cells were subcultured. Cells in the logarithmic growth phase were taken for testing. Only one cell was taken for each experiment. After cell counting, the cells were evenly inoculated in the culture plate for testing. 100 μL / well was inoculated in a 96-well plate. After routine culture for 24 hours, the culture medium was replaced. Each plate was divided into control group (0, μM) NBP and compound 1i,-4i (0.001, μM, 0.01, μM, 0.1, μM, 1.0, μM, 10, μM, 50, μM, 100, μM) concentration groups. Except for 1 well as blank control group, each group had 6 duplicate wells, and cultured for 72 hours after adding drugs. MTT (10, μL / well) was added 3 hours before terminating the culture. After the culture, the supernatant was carefully washed, and 100, μL of dimethyl sulfoxide (DMSO) was added to each well. The cells were shaken on a shaker for 10 minutes, and the OD value at 490, nm (the density of cells in the cell culture medium, usually used to indicate the number of cells) was measured to calculate the cell survival rate (Fig., 2.1). (* indicates that the difference is statistically significant. *P<, 0.05;, **P<, 0.01).
[0082] The test results show that when the compound concentration is 0.1 μM, the fluorinated butylphthalide prepared in the present application can significantly promote the proliferation of PC12 cells, and the effect is significantly stronger than that of NBP at the same concentration.
[0083] The present invention has been described in detail above in conjunction with specific implementations and exemplary examples, but these descriptions cannot be understood as limiting the present invention. Those skilled in the art understand that, without departing from the spirit and scope of the present invention, a variety of equivalent substitutions, modifications or improvements may be made to the technical solution of the present invention and its implementation methods, all of which fall within the scope of the present invention. The scope of protection of the present invention shall be subject to the attached claims.
[0084] All publications, patent applications, patents and other references mentioned in this specification are incorporated herein by reference. Unless otherwise defined, all technical and scientific terms used in this specification have the meanings conventionally understood by those skilled in the art. In the event of a conflict, the definition in this specification shall prevail.
[0085] When this specification uses the prefix "well-known to those skilled in the art", "prior art" or similar terms to introduce materials, substances, methods, steps, devices or components, etc., the objects introduced by the prefix cover those commonly used in the art when this application is filed, but also include those that are not commonly used at present but will become recognized in the art as being suitable for similar purposes.
[0086] In the context of the present specification, any matters or items not mentioned are directly applicable to those known in the art without any changes except those explicitly stated.
Claims
1. A targeted fluorinated butylphthalide, It is characterized in that It has the following general structural formula: Wherein R is located at position 3 of the benzene ring, and the R includes at least one of H, Cl, F or Br.
2. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that The synthesis steps include: S1, taking compound 5-substituted salicylaldehyde and acetylhydrazine as raw materials and adding solvent 1, reacting once and collecting to obtain compound c; S2, taking compound c and lead tetraacetate as raw materials, performing secondary reaction and collecting to obtain compound d; S3, take compound d as raw material and add pH buffer, add H 2 O 2 and NaClO 2 Afterwards, acetonitrile aqueous solution was selected as solvent 2, and the reaction was repeated three times to collect compound e; S4, under a nitrogen atmosphere, placing compound e in solvent 3, then adding 3-butenylmagnesium bromide dropwise thereto at ice-water bath temperature to mix, and adding a ring-closing agent, and performing the reaction treatment four times to collect compound g; S5, using compound g as a raw material, adding a borohydride reagent and trisodium borate to carry out five reactions, and collecting compound h; S6. Dissolve compound h in anhydrous DCM under a protective gas atmosphere, cool it down and add a fluorinating agent. After the dropwise addition, react at room temperature to prepare the targeted fluorinated butylphthalide.
3. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that In the primary reaction described in step S1, the solvent 1 includes at least one of methanol or ethanol, and the parameters of the primary reaction are: reaction treatment at 75-90° C. for 10-15 hours.
4. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that The addition ratio of compound c and lead tetraacetate in step S2 is 1:(1-1.5) in molar ratio.
5. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that The pH buffer described in step S3 is NaH 2 PO 4 , the NaH 2 PO 4 、NaClO 2 and H 2 O 2 The molar ratio between them is 1.5:(1-4):(1-3), and the stability of the three reactions is -5-5°C.
6. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that The specific preparation steps of step S4 adopt the following technical scheme: Under nitrogen atmosphere, compound e was added to tetrahydrofuran, and then 3-butenylmagnesium bromide was added dropwise in an ice-water bath. After the addition was completed, the reaction was kept warm for 20-30 minutes. After the temperature was raised to room temperature, the reaction was treated and NH 4 The reaction was quenched with Cl, 12 mol / L hydrochloric acid was added, and the temperature was raised to 65-75°C and kept warm for 45-80 min to prepare compound g.
7. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that The borohydride reagent in step S5 includes any one of 9-borabicyclo[3.3.1]nonane, borane tetrahydrofuran complex or borane dimethyl sulfide complex.
8. A method for synthesizing a targeted fluorinated butylphthalide according to claim 1, It is characterized in that The fluorinating agent in step S6 includes diethylaminosulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, pyridine-2-sulfonyl fluoride, perfluorobutylsulfonyl fluoride, sulfuryl fluoride, sulfuryl chloride and SF 4 Any of .
9. The targeted fluorinated butylphthalide according to claim 1, It is characterized in that It can be applied to the treatment of cardiovascular and cerebrovascular diseases.
Citation Information
Patent Citations
2-benzo(C) foroxone compound, its production and use
CN101029037A
Method for preparing high optical purity 3-substituted chiral phthalide compounds
CN101337955A
Benzoic acid compounds and preparation method and application thereof
CN109776466A
C-linking inhibitors of enl / af9 yeats
CN117858877A
Butylphthalide derivative as well as preparation method and application thereof
CN118619905A
